TERA STONE CO LTD has a total of 16 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2017. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are PREXTON THERAPEUTICS SA, ARROW INT LTD and MENET CHRISTEL JEANNE MARIE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 2 | |
#4 | Taiwan | 2 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Implantable devices | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nagamatsu Tomohisa | 10 |
#2 | Akaike Norio | 8 |
#3 | Tanemura Hideki | 3 |
#4 | Terada Tsunenori | 2 |
#5 | Terada Tokinori | 2 |
#6 | Nagamatsu Tomofumi | 1 |
#7 | Terada Keisuke | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020204024A1 | Thymine nucleobase-based triazolopyrimidines and production method therefor | |
CA3111171A1 | Hydrazinopurine compound and triazolopurine compound for inhibiting xanthine oxidase | |
WO2019151516A1 | Use of coenzyme factor for activation of atp production in cell | |
JP2019137673A | Use of coenzyme factor for activation of atp production in cell | |
JP2020025602A | Penis erection auxiliary tool | |
JP2018122081A | Microneedle and manufacturing method thereof | |
JP2019084308A | Penis erection auxiliary device |